Amicus Therapeutics vs Travere Therapeutics
Amicus Therapeutics vs Travere Therapeutics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Amicus Therapeutics is on 57/100 and Travere Therapeutics on 51/100.
Where each one leads
Amicus Therapeutics
- our overall score: 57/100 against 51/100
- domain rating: 66/100 against 58/100
- headcount: 625 against 125
- funding raised: $200M against $63.0M
Travere Therapeutics
- agent readiness: 39/100 against 21/100
At a glance
| Measure | Amicus Therapeutics | Travere Therapeutics |
|---|---|---|
| What it is | Biotechnology company focused on developing treatments for rare metabolic diseases. | A biopharmaceutical company focused on developing and commercializing therapies for rare diseases. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotechnology, Pharmaceuticals, Healthcare, Rare Diseases |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotech | Services |
| Founded | 2002 | 2015 |
| Headquarters | Philadelphia, United States | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Amicus Therapeutics | Travere Therapeutics |
|---|---|---|
| Employees | 625 | 125 |
| Total funding | $200M | $63.0M |
| Latest round | Series D | Convertible Note |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 57,431 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Amicus Therapeutics | Travere Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 57/100 | 51/100 |
| Traction | 60/100 | 59/100 |
| Team | 30/100 | 50/100 |
| Search visibility | 34/100 | 5/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 66/100 | 58/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Amicus Therapeutics | Travere Therapeutics |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery, Tailwind CSS |
| Analytics | Not detected | Google Tag Manager, Linkedin Insight |
Amicus Therapeutics vs Travere Therapeutics: common questions
Which is better, Amicus Therapeutics or Travere Therapeutics?
On our 0-100 score Amicus Therapeutics rates higher (57/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Amicus Therapeutics and Travere Therapeutics compare on the numbers?
Amicus Therapeutics leads on our overall score (57/100 against 51/100), domain rating (66/100 against 58/100), headcount (625 against 125), funding raised ($200M against $63.0M). Travere Therapeutics leads on agent readiness (39/100 against 21/100).
Read the full Amicus Therapeutics review and pricing or the Travere Therapeutics review and pricing. You can also browse other Amicus Therapeutics alternatives we track.